A DOUBLE-BLIND STUDY TO ASSESS THE EFFICACY AND SAFETY OF INTRANASAL ESKETAMINE FOR THE RAPID REDUCTION OF THE SYMPTOMS OF MAJOR DEPRESSIVE DISORDER, INCLUDING SUICIDAL IDEATION, IN PARTICIPANTS WHO ARE ASSESSED TO BE AT IMMINENT RISK FOR SUICIDE: